Pentostatin is a potent inhibitor of adenosine deaminase (ADA) [81], which was approved by the FDA in 1991 and became a commercial drug for the treatment of hairy cell leukemia (under the brand name Nipent). The gene discussed is ADA; the disease is hairy cell leukemia.